NewLink Genetics Corp (NASDAQ:NLNK)

47.14
Delayed Data
As of 12:14pm ET
 +2.48 / +5.55%
Today’s Change
17.32
Today|||52-Week Range
58.73
+18.59%
Year-to-Date

Today’s Trading

Previous close44.66
Today’s open46.03
Day’s range45.01 - 48.80
Volume588,450
Average volume (3 months)567,808
Market cap$1.3B
Dividend yield--
Data as of 12:14pm ET, 05/05/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-157.77%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio14.2
Price/Sales6.41
Price/Book6.13

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...-0.21-2.15%
INSMInsmed Inc-0.59-2.80%
MACKMerrimack Pharmaceut...-0.55-4.54%
ACORAcorda Therapeutics ...-1.25-4.05%
Data as of 12:29pm ET, 05/05/2015

Financials

Last reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers